Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionSimon J. Hogg, Ricky W. Johnstone, Robert M. Myers et al.|Molecular Cell|2021Cited by 167
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch toleranceMohamed Fareh, Joseph A. Trapani|Nature Communications|2021Cited by 71
Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusionsWenxin Hu, Mohamed Fareh|Research Square|2022Cited by 1